Seventh Sense Biosystems receives Edison Gold Medal Award for Touch Activated Phlebotomy technology

Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine - Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.

“We are extremely honored to be recognized by The Edison Awards for innovative achievement in healthcare diagnostics”

"We are extremely honored to be recognized by The Edison Awards for innovative achievement in healthcare diagnostics," said Doug Levinson, Ph.D., chief executive officer and co-founder of Seventh Sense Biosystems and partner at Flagship Ventures. "We've made excellent progress in the development of our TAP technology, which enables simple, painless blood acquisition in a single step. These features address fundamental needs across the diagnostics and health monitoring markets. While still in the developmental stage, we expect to be able to announce important developments with our TAP technology in the not-too-distant future."